Type 1 AIP

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Type 1 AIP trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06468709

A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence

Autoimmune pancreatitis (AIP) is an autoimmune disease with low incidence rate and involving the pancreas. In China, type I AIP is predominant. Glucocorticoids…

China86 participantsStarted 2024-06-20

Treatment: Glucocorticoids, Glucocorticoids+MMF

All recent trials (3 shown)

UnknownNot Applicable

NCT06328101

Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR)

The goal of this observational, retrospective study is to learn about cancer risk in autoimmune pancreatitis (AIP) patients. The main questions it aims to answe…

Location not specified1,000 participantsStarted 2024-05-01

CompletedPhase 1/2

NCT01584388

Rituximab in IgG4-RD: A Phase 1-2 Trial

The primary objective of this study is to evaluate the safety and effectiveness of rituximab in IgG4-RD.

Location not specified30 participantsStarted 2012-04

Treatment: Rituximab